Editor’s introduction to the initial issue of the seventh volume of GaBI Journal
EU Member States have tools to reduce costs of bestseller biologicals but can they use them?
Regulations for biotherapeutics approval in Colombia
Patent expiry dates for biologicals: 2017 update
Top developments in biosimilars during 2017
Barriers to generics policy reform: a US case study
Source URL: https://gabi-journal.net/20181-gabi-journal-table-of-contents.html
Copyright ©2025 GaBI Journal unless otherwise noted.